ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 2761 - 2775 of 5311 products
Sensus Gains China Approval of Radiation Device for Keloids
$5.00
Available
WuXi AppTec Participates in $5.9 Million Series A for Rodeo Therapeutics
$5.00
Available
Nanjing Frontier Acquires Rights to Rockefeller University HIV/AIDS Antibody
$5.00
Available
DelMar Approved to Start China Phase II Trial of Brain Cancer Treatment
$5.00
Available
Geneseeq Raises "Hundred of Millions of RMB" in C Round to Develop NGS
$5.00
Available
Lee's Pharm and SillaJen Approved for China Immunotherapy Trial
$5.00
Available
Cardinal Health Plans $1.5 Billion Sale of China Drug Distribution Business
$5.00
Available
Beijing's Symbow Closes $17 Million Funding for Surgical Navigator
$5.00
Available
Uni-Bio Raises $18.2 Million; Partners with HeungKong Group
$5.00
Available
iKang Forms $74 Million Partnership for New China Healthcare Clinics
$5.00
Available
Shanghai-Israel Fund Co-Leads $9 Million Funding of Rapid Medical
$5.00
Available
China Adds 36 Drugs to NDRL Following Major Price Cuts
$5.00
Available
C-Bridge Closes $400 Million China Healthcare Fund
$5.00
Available
Ascentage Approved to Start China Trial of Apoptosis Drug
$5.00
Available
Suzhou's PegBio Raises $20 Million from Tasly Pharma
$5.00
Available